06Oct 2023
Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension

Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension

The study explores metabolic changes preceding pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) patients, using mass spectrometry-based metabolomics. Increased kynurenine and its ratio to tryptophan (kyn/trp) were identified in SSc-PAH development. Elevated kyn/trp, detected two years before diagnosis, predicted PAH, while its slope indicated disease progression.

  • #pulmonology

Like

Save

Share